Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH2 | P05091 | 1/20 | 1.00 |
| ▸ | NPC1 | O15118 | 7/20 | 0.90 |
| ▸ | RAB9A | P51151 | 7/20 | 0.90 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.90 |
| ▸ | MEN1 | O00255 | 6/20 | 0.90 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.90 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.90 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.90 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.90 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.90 |
| ▸ | RELA | Q04206 | 3/20 | 0.90 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.90 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.90 |
| ▸ | TP53 | P04637 | 6/20 | 0.79 |
| ▸ | MAPT | P10636 | 6/20 | 0.79 |
| ▸ | HPGD | P15428 | 6/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.79 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.79 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Prunetin SCHEMBL29612430 | 1.00 | ALDH2 (1.00) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| 4',7-Dimethoxy-5-Hydroxygenistein SCHEMBL572108 | 0.95 | RAB9A (1.00) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| 5-Hydroxy-7-Methoxyisoflavone SCHEMBL6142401 | 0.91 | RAB9A (0.83) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL28788159 | 0.90 | KDM4E (0.83) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL16226987 | 0.90 | ALDH2 (0.81) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL2313317 | 0.90 | NPC1 (0.81) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| Biochanin SCHEMBL29410271 | 0.88 | RAB9A (1.00) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| Biochanin SCHEMBL61258 | 0.88 | RAB9A (1.00) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| Genistein SCHEMBL18241115 | 0.88 | MEN1 (0.89) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL2751306 | 0.87 | NPC1 (0.77) | ALDH2NPC1RAB9ASMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1378 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121276055-B | Function and application of lysine deficiency type protein kinase 2 inhibitor in inhibiting ventricular remodeling | 温州医科大学附属第一医院 | 2026-05-19 | — | — | CN | claimed |
| EP-2603098-B1 | METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER | FIRMENICH INCORPORATED (US) | 2025-08-06 | — | — | EP | claimed |
| CN-120131496-A | Composition for improving skin problems caused by unbalanced skin homeostasis and preparation method thereof | 中央民族大学 | 2025-06-13 | — | — | CN | claimed |
| CN-119925454-A | Application of cajan leaf in rats with chronic myelosuppression caused by MTX | 浙江中医药大学 | 2025-05-06 | — | — | CN | claimed |
| CN-119780447-A | Biomarker for early pregnancy related state of dairy cows and application thereof | 宁夏大学 | 2025-04-08 | — | — | CN | claimed |
| US-20250051551-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2025-02-13 | — | — | US | claimed |
| CN-118831107-A | Ural licorice extract and preparation method and application thereof | 成都大学 | 2024-10-25 | — | — | CN | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| US-20240042396-A1 | Polymeric Membrane | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2024-02-08 | — | — | US | claimed |
| CN-117298006-A | Nanoparticle as well as preparation method and application thereof | 上海澄穆实业发展有限公司 | 2023-12-29 | — | — | CN | claimed |
| WO-2002100478-A9 | ACCELERATORS FOR INCREASING THE RATE OF FORMATION OF FREE RADICALS AND REACTIVE OXYGEN SPECIES | CAVALIER DISCOVERY (US) | 2003-03-27 | — | — | WO | claimed |
| WO-2002100478-A2 | ACCELERATORS FOR INCREASING THE RATE OF FORMATION OF FREE RADICALS AND REACTIVE OXYGEN SPECIES | CAVALIER DISCOVERY (US) | 2002-12-19 | — | — | WO | claimed |
| WO-2002087517-A2 | USE OF ISOFLAVONOIDS IN COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR THE PROPHYLAXIS OR TREATMENT OF SENSITIVE SKIN | BEIERSDORF AG (DE) | 2002-11-07 | — | — | WO | claimed |
| US-20020107282-A1 | Cosmetic composition containing an aminophenol derivative and an isoflavonoid | L'OREAL (FR) | 2002-08-08 | — | — | US | claimed |
| CN-1352935-A | Cosmetics composition containing aminophenol derivatives and isoflavone like substance | OREAL (FR) | 2002-06-12 | — | — | CN | claimed |
| US-6329422-B1 | ENHANCING, STIMULATING CHLORIDE TRANSPORT IN EPITHELIAL CELLS; FLAVONE OR ISOFLAVONE OR A STEREOISOMER THEREOF. | CHILDREN'S HOSPITAL OAKLAND RESEARCH INSTITUTE | 2001-12-11 | — | — | US | claimed |
| EP-1024803-A1 | FLAVONOIDS FOR CYSTIC FIBROSIS THERAPY | Children's Hospital Medical Center of Northern California (US) | 2000-08-09 | — | — | EP | claimed |
| US-5958946-A | APPLYING GLUCURONIC ACID | GILLETTE COMPANY, THE (A DELAWARE CORPORATION) | 1999-09-28 | — | — | US | claimed |
| WO-1999018953-A1 | FLAVONOIDS FOR CYSTIC FIBROSIS THERAPY | CHILDREN'S HOSPITAL MEDICAL CENTER OF NORTHERN CALIFORNIA (US) | 1999-04-22 | — | — | WO | claimed |
| WO-1998021946-A1 | COMPOSITION AND TREATMENT FOR PERSISTENT REPRODUCTIVE TRANSITION SYMPTOMS | INTERNUTRIA, INC. (US) | 1998-05-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020107282-A1 | Cosmetic composition containing an aminophenol derivative and an isoflavonoid | TYR, CYP19A1, EYA3 | ALDH2 2429/4885NPC1 4489/4885RAB9A 3324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.